Natural products in the reprogramming of cancer epigenetics
Creators
- 1. Department of Biotechnology, Faculty of Natural Sciences, Jamia Millia Islamia, New Delhi, 110025 (India)
Description
Highlights: • Cancer epigenetic mechanisms provide significant insights into cancer progression. • Aberrant epigenetic processes are reversible in nature and holds great prospect as anti- cancer therapy. • Natural products are evidenced to play noteworthy role as epi-drugs. • Resveratrol, Quercetin, Genistein among other phytochemicals differentially modulates key epigenetic enzymes. • Dietary epigenetic regulators can maximize clinical benefits to patients, hence expanding cancer management prospects. Owing to the technological advancements, including next generation sequencing, the significance of deregulated epigenetic mechanisms in cancer initiation, progression and treatment has become evident. The accumulating knowledge relating to the epigenetic markers viz. DNA methylation, Histone modifications and non-coding RNAs make them one of the most interesting candidates for developing anti-cancer therapies. The reversibility of deregulated epigenetic mechanisms through environmental and dietary factors opens numerous avenues in the field of chemoprevention and drug development. Recent studies have proven that plant-derived natural products encompass a great potential in targeting epigenetic signatures in cancer and numerous natural products are being explored for their possibility to be considered as "epi-drug". This review intends to highlight the major aberrant epigenetic mechanisms and summarizes the essential functions of natural products like Resveratrol, Quercetin, Genistein, EGCG, Curcumin, Sulforaphane, Apigenin, Parthenolide and Berberine in modulating these aberrations. This knowledge along with the challenges and limitations in this field has potential and wider implications in developing novel and successful therapeutic strategies. The increased focus in the area will possibly provide a better understanding for the development of dietary supplements and/or drugs either alone or in combination. The interaction of epigenetics with different hallmarks of cancer and how natural products can be utilized to target them will also be interesting in the future therapeutic approaches.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.taap.2021.115467Additional details
Identifiers
- DOI
- 10.1016/j.taap.2021.115467;
- PII
- S0041008X21000740;
Publishing Information
- Journal Title
- Toxicology and Applied Pharmacology
- Journal Volume
- 417
- Journal Page Range
- vp.
- ISSN
- 0041-008X
- CODEN
- TXAPA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 54051942
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- CURCUMIN; DNA; DRUGS; ENZYMES; HISTONES; METHYLATION; NEOPLASMS; PATIENTS; QUERCETIN; REVIEWS; RNA; THERAPY
- Descriptors DEC
- AROMATICS; CHEMICAL REACTIONS; DISEASES; DOCUMENT TYPES; DYES; ETHERS; FLAVONES; FLAVONOIDS; HETEROCYCLIC COMPOUNDS; HETEROCYCLIC OXYGEN COMPOUNDS; HYDROCARBONS; HYDROXY COMPOUNDS; KETONES; MEDICINE; NUCLEIC ACIDS; ORGANIC COMPOUNDS; ORGANIC OXYGEN COMPOUNDS; PHENOLS; POLYPHENOLS; PROTEINS; PYRANS
Optional Information
- Copyright
- Copyright (c) 2021 Elsevier Inc. All rights reserved.